Hale and Dorr represented Millennium Pharmaceuticals, Inc. in its June 30, 2003 deal with Ortho Biotech Products, L.P., a Johnson & Johnson subsidiary, to jointly develop and commercialize Millennium’s Velcade product outside the United States.…